|
Company introduction Focus on the full life cycle of nuclear medicine products ———— Founded in 2021, Norroy bioscience Co., Ltd. is a biomedical enterprise dedicated to pioneering research and innovative diagnosis and treatment in the field of radio pharmaceuticals. Norroy's focused approach on addressing unmet clinical needs in urinary system tumors and gastrointestinal tumors has driven a fast proof of concept and rapid commercialization of our two-wheeled strategy. This strategic development aligns with China's original layout research innovation in nuclear medicine, emphasizing excellence in both the First Class and Best in Class dimensions. Norroy possesses a comprehensive expertise from drug discovery to commercialization of nuclear medicine, supported by a highly skilled and experienced professional team. Under the leadership of a a professional team with an extensive background and profound capabilities, we have successfully established a rapid high-throughput preclinical and clinical screening system. Moreover, our team has accomplished numerous target selection and clinical validation projects as part of our development strategy, leading to the advancement of three original innovative nuclear medicine treatments into the formal clinical Phase I/II trials approval by FDA and NMPA. Norroy Wuxi manufacturing and R&D base was constructed in accordance with GMP and officially commenced operations in 2023, while also obtaining the Chinese Radiation safety permit. Sunmao medical is the high-end smart brand of Norroy, specializing in the research and development of nuclear medicine automation equipment. Sunmao integrates research, development, production, and sales to provide nuclear medicine integrated solutions for medical institutions, pharmaceutical companies, research institutions, etc. Company focuses on the whole life cycle of nuclear medicine, and our business covers the whole industrial chain of nuclear medicine. The core team has more than 15 years of radiochemical and automated synthesis development experience, dominated by the original nuclear medicine automation equipment, purification and packaging of products cover species, while expanding nuclear medicine supply business infrastructure integration, dominates by independent development of nuclear medicine automation equipment, product coverage of nuclide purification and packing and so on function; meanwhile, we expand the integrated supply business of nuclear medicine infrastructure, and strive to become an international Chinese brand of nuclear medicine equipment driven by scientific innovation, and contribute to the global industrialization of nuclear medicine 4.0. |
 |
86-0510-88786189Address: No.35-208, Changjiangnan Road, XinWu District, Wuxi, China
Mail address: bd@norroybioscience.com
Website: www.biznes2.com
